PRELUDE CAPITAL MANAGEMENT, LLC - OPIANT PHARMACEUTICALS INC ownership

OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 23 filers reported holding OPIANT PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of OPIANT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$10,000
-23.1%
1,400
-4.6%
0.00%
-100.0%
Q2 2020$13,000
-7.1%
1,4670.0%0.00%0.0%
Q1 2020$14,000
-54.8%
1,467
-32.1%
0.00%0.0%
Q4 2019$31,000
-79.5%
2,162
-81.3%
0.00%
-88.9%
Q1 2019$151,000
-56.9%
11,533
-52.3%
0.01%
-60.9%
Q4 2018$350,00024,1970.02%
Other shareholders
OPIANT PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 80,000$850,0000.77%
PERRITT CAPITAL MANAGEMENT INC 32,000$340,0000.18%
Newbridge Financial Services Group, Inc. 5,300$56,0000.04%
Mesirow Financial Investment Management, Inc. 753$8,0000.02%
Marquette Asset Management, LLC 7,941$84,0000.02%
Renaissance Technologies 222,815$2,366,0000.00%
ACADIAN ASSET MANAGEMENT LLC 59,831$635,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 10,400$110,0000.00%
American Research & Management Co. 300$3,0000.00%
Certified Advisory Corp 500$5,0000.00%
View complete list of OPIANT PHARMACEUTICALS INC shareholders